UCLH is well-known throughout the UK as a centre of excellence in the management of patients with Hodgkin’s and non-Hodgkin’s lymphoma. The lymphoma service treats patients with newly-diagnosed lymphoma as well as those with relapsed lymphoma.
The consultants are known nationally and internationally for their expertise in the diagnosis and management of patients with lymphoma. They receive referrals from across the UK as well as from abroad.
The lymphoma service is well supported by three experienced lymphoma clinical nurse specialists as well as a lymphoma research nurse.
All treatment modalities are available at UCLH including chemotherapy, monoclonal antibody treatments, state-of-the-art radiotherapy, stem cell transplantation (both autologous and allogeneic (donor) transplantation). Unusually we are able to provide emergency chemotherapy and intrathecal chemotherapy for those patients who require it. We run a combined lymphoma/HIV clinic for patients with lymphoma who are infected with HIV as these patients benefit from a combined approach.
The hospital has its own PET/CT scanner which allows the most up-to-date imaging of patients as a matter of routine.
Some patients with lymphoma require complex inpatient treatments. We are proud to be able to provide expert professional nursing in our haematology and oncology wards. The hospital also has an infectious diseases ward and one of the biggest intensive care units (ICU) in Europe. These facilities help us deliver the best possible care for our patients safely.
We have a large number of clinical trials open and patients are offered entry into these trials if they are eligible to do so.
We have close links with all the hospitals in the North London Cancer Network and also receive regular referrals from Hertfordshire, Middlesex, Essex, Surrey and Sussex. We see over 200 patients a year who require treatment either for a new diagnosis of lymphoma or for the treatment of relapse.
The research unit plays a pivotal role in ensuring the development of the best treatments for patients with lymphoma. Patients may be asked if they would like to take part in a research study or clinical trial. They will be given written information and be able to speak to a consultant and research nurse. Sometimes trials compare two well established treatments. Other times newer drugs are evaluated in the trials. There is no obligation to take part.
The lymphoma teams work with other health care professionals both within the hospital and in the community to ensure that the patient's treatment plan is optimal. There is a constant dialogue between the haematologists, oncologists, radiologists, pathologists and clinical nurse specialists.
The lymphoma clinical nurse specialists (CNSs) support patients from the time of diagnosis to well after treatment is complete. They play a role in bringing together patients’ individual care while providing support and advocacy at every stage of their cancer journey, to longer-term follow-up and palliation.
It is likely that you will be seen by several members of the team during your series of visits to the unit.